Leerink Swann Starts Anthera Pharma (ANTH) at Outperform; Compelling Risk-Reward with Advanced Programs in SLE and ACS
Go back to Leerink Swann Starts Anthera Pharma (ANTH) at Outperform; Compelling Risk-Reward with Advanced Programs in SLE and ACS| ANTHERA PHARMA (AMEX: ANTH) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $6.08 | |||
| Open | $0.00 | 52 Week Low | $1.72 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.47 | |||
| Volume | 124 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.15 | 52 Week High | $45.58 | |||
| Open | $51.15 | 52 Week Low | $37.82 | |||
| Day High | $51.15 | P/E | N/A | |||
| Day Low | $51.15 | EPS | $0.00 | |||
| Volume | 24,993 | |||||
| Human Genome Sciences, Inc. (NASDAQ: HGSI) | Delayed: 14.24 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.24 | 52 Week High | $16.58 | |||
| Open | $55.80 | 52 Week Low | $6.51 | |||
| Day High | $14.24 | P/E | N/A | |||
| Day Low | $14.24 | EPS | $-1.79 | |||
| Volume | 557,147 | |||||
